Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Mesa Laboratories, Inc.

Stage 2 · Advancing · week 10

As of Oct 22, 2026, Mesa Laboratories is in Stage 2, the uptrend phase, now in week 10 (since Aug 19, 2026). It closed at $129.10, 9.2% below its 52-week high and above its 200-day average, which is rising.

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. More about the company

$129.10
-0.08% today
$722M · Small cap
Market Neutral — Fading

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 5 in Scientific & Technical Instruments · #1 of 242 in Information Technology

Is MLAB early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 14w
S1 19w
S4 25w
S1 16w
S2 22w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 2w → S1 4w → S4 14w → S1 19w → S2 5w → S3 6w → S4 1w → S3 1w → S2 12w → S3 8w → S2 11w → S3 5w → S4 25w → S1 16w → S2 22w → S3 5w → S2 9w current
Total tracked: 166 weeks across 17 stage runs.

MLAB among Scientific & Technical Instruments3rd of 32 by relative strength

All 32 →
Stocks in Scientific & Technical Instruments ranked by relative strength, with stage and one-month change
#StockStageRS1M
1KEYSStage 2 · wk 493−11.8%
2COHRStage 4 · wk 192−30.9%
3MLABStage 2 · wk 1090−2.9%
4VPGStage 4 · wk 385−24.5%
5ITRNStage 4 · wk 283−2.9%
6MKSIStage 4 · wk 382−25.4%
7STStage 3 · wk 1174−2.0%
8NOVTStage 3 · wk 1071−5.4%
vs 52W High
-9.2%
$70.15 lo$142.23 hi
9.2% below 52W high, pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 10
1w13w26w
Week 10, early Stage 2
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
25.8%
200 DMA: $102.63 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
0.54x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-2.9%
3M
+32.6%
6M
+33.6%
YTD
+63.3%
1Y
+64.6%
Scan Membership
Breakout Watch
Latest: 2025-01-03
9 appearances in last 60 days. First seen: 2018-11-29.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 10 · Vol 0.54x
2026-10-21S2
Wk 9 · Vol 0.59x
2026-10-20S2
Wk 9 · Vol 0.56x
2026-10-19S2
Wk 9 · Vol 0.51x
2026-10-16S2
Wk 9 · Vol 0.54x
2026-10-15S2
Wk 9 · Vol 0.72x
2026-10-14S2
Wk 8 · Vol 0.56x
2026-10-13S2
Wk 8 · Vol 0.76x
2026-10-12S2
Wk 8 · Vol 0.74x
2026-10-09S2
Wk 8 · Vol 0.59x
2026-10-08S2
Wk 8 · Vol 1.08x
2026-10-07S2
Wk 7 · Vol 0.50x
Moving averages & range
50 DMA
$126.36
200 DMA
$102.63
52W High
$142.23
52W Low
$70.15
5D Low
$122.48
Resistance levels (recent highs)
20d High
$142.23
60d High
$142.23
120d High
$142.23
250d High
$142.23
Next resistance
+10.2%
to 20d High
P/E (TTM)
151.9
Forward 12.6
Earnings Growth (YoY)
-42.4%
Revenue +1.0%
ROE
+2.7%
Profit margin +1.9%
Dividend Yield
0.49%
P/B 3.8

Mesa Laboratories: quick answers

What stage is Mesa Laboratories in?

As of Oct 22, 2026, Mesa Laboratories (MLAB) is in Stage 2, the uptrend phase. It entered Stage 2 on Aug 19, 2026 and is in week 10. What the four stages mean

Is Mesa Laboratories in an uptrend?

Yes. Mesa Laboratories is in a Stage 2 uptrend. It trades 25.8% above its 200-day average, which is rising.

How far is Mesa Laboratories from its 52-week high?

Mesa Laboratories closed at $129.10 on Oct 22, 2026, 9.2% below its 52-week high of $142.23. Its 52-week low is $70.15.

How has Mesa Laboratories performed over the past year?

As of Oct 22, 2026, Mesa Laboratories is up 64.6% over the past year and up 63.3% so far in 2026.

Which sector and industry is Mesa Laboratories in?

Mesa Laboratories is in the Scientific & Technical Instruments industry, part of the Information Technology sector.

About this companyInformation Technology· Scientific & Technical Instruments

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; and PurePep Symphony and Chorus instruments for peptide synthesis. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as renal care, gas flow, environmental and process monitoring, and torque testing in pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental applications. This segment's products include continuous monitoring systems, data loggers, and torque testing systems under the DialyGuard, DryCal, DataTrace, and ViewPoint brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.